Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.

BACKGROUND Mycobacterium avium and Mycobacterium intracellulare are grouped together as the M avium complex; however, little is known about the clinical impact of this species differentiation. This study compared the clinical features and prognoses of patients with M avium and M intracellulare lung disease. METHODS From 2000 to 2009, 590 patients were given a new diagnosis of M avium complex lung disease; 323 (55%) had M avium lung disease, and 267 (45%) had M intracellulare lung disease. RESULTS Compared with the patients with M avium lung disease, the patients with M intracellulare lung disease were more likely to have the following characteristics: older age (64 vs 59 years, P = .002), a lower BMI (19.5 kg/m² vs 20.6 kg/m², P < .001), respiratory symptoms such as cough (84% vs 74%, P = .005), a history of previous treatment for TB (51% vs 31%, P < .001), the fibrocavitary form of the disease (26% vs 13%, P < .001), smear-positive sputum (56% vs 38%, P < .001), antibiotic therapy during the 24 months of follow-up (58% vs 42%, P < .001), and an unfavorable microbiologic response after combination antibiotic treatment (56% vs 74%, P = .001). CONCLUSIONS Patients with M intracellulare lung disease exhibited a more severe presentation and had a worse prognosis than patients with M avium lung disease in terms of disease progression and treatment response. Therefore, species differentiation between M avium and M intracellulare may have prognostic and therapeutic implications.

[1]  S. Yamori,et al.  Comparison of prognosis of pulmonary diseases caused by Mycobacterium avium and by Mycobacterium intracellulare. , 1992, Chest.

[2]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[3]  R. Thomson.  Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections , 2010, Emerging infectious diseases.

[4]  S. Ichiyama,et al.  Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. , 2008, American journal of respiratory and critical care medicine.

[5]  C. Daley,et al.  Pulmonary non-tuberculous mycobacterial infections. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  H. Tomioka,et al.  Comparison of the Virulence for Mice of Mycobacterium avium and Mycobacterium intracellulare Identified by DNA Probe Test , 1993, Microbiology and immunology.

[7]  S. Sone,et al.  Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. , 1999, American journal of respiratory and critical care medicine.

[8]  G. Bai,et al.  Species Identification of Mycobacteria by PCR-Restriction Fragment Length Polymorphism of therpoB Gene , 2000, Journal of Clinical Microbiology.

[9]  D. van Soolingen,et al.  Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands , 2009, Thorax.

[10]  S. Muro,et al.  Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  A. Chaiprasert,et al.  Distribution of hsp65 PCR-Restriction Enzyme Analysis Patterns among Mycobacterium avium Complex Isolates in Thailand , 2006, Journal of Clinical Microbiology.

[12]  T. Kanauchi,et al.  Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. , 2012, American journal of respiratory and critical care medicine.

[13]  L. Guthertz,et al.  Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. , 1989, The Journal of infectious diseases.

[14]  Young Kil Park,et al.  Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. , 2006, Chest.

[15]  S. Garay,et al.  Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. , 2006, American journal of respiratory and critical care medicine.

[16]  O. Kwon,et al.  Standardized Combination Antibiotic Treatment of Mycobacterium avium Complex Lung Disease , 2010, Yonsei medical journal.

[17]  K. Winthrop,et al.  Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. , 2010, American journal of respiratory and critical care medicine.

[18]  Mary Ann Blosky,et al.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. , 2010, American journal of respiratory and critical care medicine.

[19]  T. Marras,et al.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 , 2007, Thorax.

[20]  William Girard,et al.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. , 2006, American journal of respiratory and critical care medicine.

[21]  D. van Soolingen,et al.  Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia , 2011, Emerging infectious diseases.

[22]  J. Yim,et al.  Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[23]  T. Marras,et al.  The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada , 2010, European Respiratory Journal.

[24]  S. Field,et al.  Mycobacterium avium complex pulmonary disease in patients without HIV infection. , 2004, Chest.

[25]  M. Kaku,et al.  A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections. , 1993, Chest.

[26]  M. Truong,et al.  Clinical Significance and Epidemiologic Analyses of Mycobacterium avium and Mycobacterium intracellulare among Patients without AIDS , 2005, Journal of Clinical Microbiology.

[27]  M. Chung,et al.  Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  M. Chung,et al.  Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection , 2005, Journal of Korean medical science.

[29]  C. Daley,et al.  Diagnosis and Treatment of Infections due to Mycobacterium avium Complex , 2008, Seminars in respiratory and critical care medicine.

[30]  Young Kil Park,et al.  Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans , 2008, Journal of clinical laboratory analysis.

[31]  S. Holland,et al.  Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. , 2009, The Journal of allergy and clinical immunology.

[32]  C. F. von Reyn,et al.  Clinical and Epidemiological Correlates of Genotypes within the Mycobacterium avium Complex Defined by Restriction and Sequence Analysis of hsp65 , 2002, Journal of Clinical Microbiology.

[33]  M. Ebina,et al.  Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection , 2009, Thorax.